Biocryst Pharmaceuticals (BCRX) Tax Provisions (2021 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Tax Provisions came in at $1.0 million in Q1 2026, up 38.29% YoY from $726000.0 in Q1 2025, and down 53.78% on a QoQ basis from $2.2 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Tax Provisions (2021 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 6 years of Tax Provisions data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Tax Provisions rose 38.29% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 66.43% YoY) and the FY2025 annual result came in at $3.5 million, up 83.19% from the prior year.
- Tax Provisions slipped to $1.0 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.2 million in Q4 2025 to a low of -$1.4 million in Q4 2023.
- A 5-year average of $559058.8 and a median of $671000.0 in 2023 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions plunged 1982.89% — and 2025, when it soared 714.53%.
- Tracing BCRX's Tax Provisions over 5 years: stood at $76000.0 in 2022, then sank by 1982.89% to -$1.4 million in 2023, then surged by 156.18% to $804000.0 in 2024, then soared by 170.15% to $2.2 million in 2025, then sank by 53.78% to $1.0 million in 2026.
- The last three Tax Provisions figures came in at $1.0 million (Q1 2026), $2.2 million (Q4 2025), and -$769000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | -769,000.00 |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 726,000.00 |
| Dec 31, 2024 | 804,000.00 |
| Sep 30, 2024 | 586,000.00 |
| Jun 30, 2024 | 172,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | -1.43 Mn |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 740,000.00 |
| Mar 31, 2023 | 671,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 279,000.00 |
| Dec 31, 2021 | 2.25 Mn |